ENDEAVOUR, ASPIRE and TOURMALINE-MM1 trial results for multiple myeloma
Michel Delforge • 26 May 2016
The Phase II clinical trial of ixazumib, the first oral proteasome inhibitor in MM
Joseph Mikhael • 5 Feb 2016
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.